Rydex Health Care Fund Class A (RYHEX)

Fund Assets	19.53M
Expense Ratio	1.65%
Min. Investment	$2,500
Turnover	244.00%
Dividend (ttm)	3.00
Dividend Yield	2.15%
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	Dec 16, 2025

Previous Close	140.22
YTD Return	16.00%
1-Year Return	30.25%
5-Year Return	24.09%
52-Week Low	109.03
52-Week High	140.22
Beta (5Y)	0.80
Holdings	135
Inception Date	Sep 1, 2004

About RYHEX

Rydex Series Funds Health Care Fund Class A is a mutual fund that seeks capital appreciation by investing substantially all of its net assets in equity securities of companies involved in the health care industry. This includes a diverse range of health care companies, such as those in pharmaceuticals, biotechnology, medical devices, health care services, and related sectors. The fund normally allocates at least 80% of its assets to these equities, providing investors with targeted exposure to the dynamic health care market segment. Managed by a team at Security Investors, LLC, under the Guggenheim Investments umbrella, it offers Class A shares with a front-end sales load structure and annual distributions when applicable. Its portfolio typically features a mix of large-cap leaders and other health care firms, emphasizing domestic stocks with a small portion in foreign equities. Rydex Series Funds Health Care Fund Class A serves as a specialized vehicle for those seeking focused participation in health care sector growth within a mutual fund format. Inception for Class A shares was September 1, 2004.

• Fund Family: Rydex Funds
• Category: Health
• Performance Rating: Average
• Risk Rating: Average
• Stock Exchange: NASDAQ
• Ticker Symbol: RYHEX
• Share Class: Class A
• Index: S&P 500 TR

Performance

RYHEX had a total return of 30.25% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.18%.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

Symbol	Provider	Name	Expense Ratio
FIKCX	Fidelity	Fidelity Advisor Health Care Z	0.56%
FSPHX	Fidelity	Fidelity Select Health Care Portfolio	0.62%
FIJYX	Fidelity	Fidelity Advisor Biotechnology Z	0.58%
FSHCX	Fidelity	Fidelity Select Health Care Services Portfolio	0.67%
FBTAX	Fidelity	Fidelity Advisor Biotechnology A	0.96%

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
RYHIX	Investor Class	1.40%
RYHAX	Class H	1.65%
RYHCX	Class C	2.40%

Top 10 Holdings

24.47% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	4.32%
Johnson & Johnson	JNJ	3.42%
AbbVie Inc.	ABBV	2.99%
UnitedHealth Group Incorporated	UNH	2.64%
Merck & Co., Inc.	MRK	2.42%
Thermo Fisher Scientific Inc.	TMO	1.91%
Amgen Inc.	AMGN	1.85%
Abbott Laboratories	ABT	1.68%
Gilead Sciences, Inc.	GILD	1.65%
Vertex Pharmaceuticals Incorporated	VRTX	1.59%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 16, 2025	$2.99915	Dec 16, 2025
Dec 20, 2022	$1.88996	Dec 20, 2022
Dec 8, 2021	$4.23477	Dec 8, 2021
Dec 9, 2020	$10.14672	Dec 9, 2020
Dec 11, 2018	$1.51173	Dec 11, 2018
Dec 12, 2017	$7.88517	Dec 12, 2017

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Aug 27, 2026

Data Sources Report a data error